Archive for the ‘Zika’ Category

Learning From the French Regarding Lyme Disease

http://www.wbur.org/commonhealth/2017/08/11/french-lyme-disease  (Listen to audio here)

What We Can Learn From The French About Fighting Lyme Disease

Tire-Tic is a tick extraction tool distributed in France. (Jesse Costa/WBUR)

Part of our Losing to Lyme series

Most visitors go to the Alsace region of France to drink its fine white wines and to Lorraine for its ornate architecture. I went to see if the French are dealing with Lyme disease better than we are here in Massachusetts and across the U.S.

Last September, France became the first country to release a national plan to address tick-borne diseases like Lyme. It ranges from ramped-up surveillance of ticks and infections to better treatment protocols and diagnostic tests.

In May, Canada released its own federal action plan to address Lyme. In the United States, we have at least 10 times more cases of Lyme than France or Canada: over 300,000 cases annually, compared to about 33,000 in France and probably less than 10,000 in Canada. But we lag far behind on concerted national action, even as the problem of tick-borne diseases continues to grow.

So what can we learn from the French? A lot, I concluded. The officials, doctors and researchers I spoke with there emphasized that their national plan is still evolving. But already they are launching a sweeping initiative to tackle Lyme disease as a major public health problem.

An All-Hands-On-Deck Approach

Tune in to French radio this summer and you might hear this: Birds chirping, footsteps crunching on forest leaves, and a woman asking, “Ehhh, have you thought about protecting yourself against ticks?”

C’est bon,” her male companion responds jovially. “The little beast won’t eat the big one.”

The woman shares a few anti-tick tips to avoid catching la maladie de Lyme, and the spot finishes up with a slogan: Against ticks — tiques in French — “to be watchful is to win.”

The 30-second spot from France’s public health agency is one of many on the airwaves this summer; others include experts answering questions about ticks and Lyme disease itself.

You’ll also find posters detailing how to prevent tick bites in pharmacies, medical clinics and even the Alpine Club of Nancy, housed in an art nouveau building just off the famous Place Stanislas downtown.

One of the new French signs warning of ticks at forest trailheads. (David Scales for WBUR)
One of the new French signs warning of ticks at forest trailheads. (David Scales for WBUR)

At the entrance to forests in eastern France — in Kintzheim in Alsace, or La Haye in Lorraine — you’ll find more “beware of ticks” signs, with tips on what to look for and how to remove them.

France doesn’t have a magic prevention toolkit. In fact, much of what they’re doing — education, tracking ticks and counting Lyme cases — is similar to what we do, some of it at the federal level and some of it piecemeal, at the local level. They’re just doing much more of it, more thoroughly and robustly, than we do.

And they don’t need to rely on local public health heroes, as we often do in the United States. Here in Massachusetts, the heroes include Larry Dapsis, the entomologist for Barnstable County, who spends the spring and summer doing 70 tick-borne disease workshops up and down Cape Cod. Or Catherine Brown, the state public health veterinarian, who finds time among her innumerable responsibilities to also teach the public about Lyme. Their personal passion is key because their tick-related work runs on a shoestring.

France, in contrast, is putting strong systems in place and attacking the problem from multiple angles — coordinating between government agencies and recognizing that the complex problem of Lyme disease requires multiple simultaneous solutions.

“If we do a good job at prevention, we’ll have fewer patients who end up seeking care and struggling in the medical system,” said Lucie Chouin, a public health official for the Greater Eastern region of France. “For me, prevention is part of a package; if we only do so much, and do not do anything upstream, the problem won’t be resolved.”

And France is allotting the money to take that holistic approach. Though it does not specify a budget, the national French plan sets the priorities at high levels of government. The then-minister of health herself, Marisol Touraine, announced the release of the national plan this past September.

2,000 Forest Signs

Take education. Along with those radio spots and posters in the northeast of France, the government is paying to educate hundreds of doctors and place thousands of pamphlets in medical offices. At the cost of about 1,000 euros each it’s placing 2,000 of those “beware of ticks” signs across the country.

Tick and Lyme disease prevention posters and pamphlets from France. (Jesse Costa/WBUR)
Tick and Lyme disease prevention posters and pamphlets from France. (Jesse Costa/WBUR)

That is a much more sweeping and energetic program than I’ve seen in the Lyme hotbed of Massachusetts, which leaves most Lyme disease issues to local officials. The state produces free educational materials, but it’s up to towns to use them. If a town wants to go beyond education — which experts think will be required to turn the tide against tick borne illnesses — they need to drum up the cash. So far, few towns do.

Compare that to what the all-hands-on-deck approach against Lyme looks like in France. Initiatives there, in addition to better educating the public, include:

  • Public health “Regional Intervention Units” to track Lyme and tick-borne diseases better, including an ongoing multi-year study of the number of Lyme cases in the Lyme-heavy northeast region
  • The Agricultural Social Mutual Fund, a social security system to protect agricultural workers, is supporting pamphlets and a push to pinpoint tick hot spots
  • And the medical system and the public health department are doing most of the heavy lifting to carry out the national plan

Pragmatic Science

Here’s something else France has that we don’t: an app that lets everyone report tick bites on themselves or their pets. It’s called Signalement Tique and was just released by the National Institute for Agricultural Research in July.

A screenshot from new French app for tracking tick encounters. (Courtesy Joseph Koehly)
A screenshot from new French app for tracking tick encounters. (Courtesy Joseph Koehly)

The app is just one of many French initiatives under way to improve research on ticks and Lyme. The national plan puts heavy emphasis on practical research, and the ecology research that is crucial for fighting Lyme does not fall through funding cracks as it does here in the U.S.

Here, about two-thirds of our annual Lyme research spending is on basic biology. Research budgets tend to be smaller in France, but the emphasis is also different — more focus on projects that have immediate practical applications, such as identifying local tick hotspots or tracking what proportion of ticks carry diseases.

“We get money from time to time, and we’re used to working with less money for basic research,” said Benoit Jaulhac, an expert on Borrelia — the Lyme bacterium — and director of the National Reference Center for Borrelia in Strasbourg, where all French Lyme researchers are located. (No, we don’t have one of those either.)

But because some funding comes from the Institute for Public Health Surveillance, much of their research must yield “immediately applicable information,” Jaulhac said, such as tick-tracking and diagnostic tests. Few resources go to tick-tracking here; public health official argue that it is because tick numbers can vary dramatically from spot to spot, but another reason is that most simply don’t have the money for it.

Some particularly intriguing French research still in the planning phase: a study on what happens to people who get tick bites, looking not just at tick-borne illness but at whether the tick bites themselves could make people chronically sick over time.

The National Borrelia Center is also working with the the National Institute for Agricultural Research on tick surveillance and ecology research to figure out what could stem the tick invasion. In the U.S., the focus on basic biological research leaves ecologists often struggling to find grants to fund their tick-borne disease research.

Months Of Medical Care In A Day

Abdel Hafiz Abid can remember the exact day he became ill: July 5, 2014. He started to feel pain in his left leg, and particularly his ankle. At first it was occasional, but soon it afflicted him every day, and extended to his knees and back. He was also beset by fatigue — “Walking 200 meters feels like I’ve walked 25 kilometers,” he said — and by problems with short-term memory.

Family members suggested he had Lyme disease. “We vaguely talked about it, like everybody else,” he said. A number of them have that diagnosis, and he lives outside the city of Metz, in the Lorraine region of northern France, which has one of the country’s highest rates of Lyme.

Lyme disease clinic patient Abdel Hafiz Abid. (David Scales for WBUR)
Lyme disease clinic patient Abdel Hafiz Abid. (David Scales for WBUR)

The testing began. In a 2-inch black notebook, Abid keeps multiple yellow folders from each different laboratory and clinic he’s visited on his quest for a diagnosis. He’s been to clinics in France and one in Germany, spent thousands of euros outside what the national health plan covers, and tried multiple courses of antibiotics, some as long as six months. So far, nothing has worked.

So he came recently to Nancy, the biggest city in Lorraine, to spend the day at a new multi-disciplinary Lyme disease clinic run by Dr. François Goehringer, an infectious disease doctor.

“Ten years ago we used to say, ‘It’s not Lyme, we don’t know what it is,’ and they left our clinic with us saying, ‘We know you’re sick, but we don’t know what it is, au revoir, monsieur, au revoir, madam,'” Goehringer explained. Patients would then bounce from specialist to specialist getting different, confusing answers.

“We decided we could gain a lot of efficiency by trying to offer a day of hospitalization at the center of our approach,” he said. “The maximum of complementary exams and specialist advice to be able to weigh in on what the patient is suffering from.”

There are many specialized Lyme clinics in France and in the United States as well. What makes the Nancy clinic stand out is that one-stop shop organization. For a day, patients come to the hospital, get all the tests and scans, see various specialists and get started on treatments that fit their diagnosis.

Goehringer and his intern, Dr. Marie Geisler, go through Abid’s black folder in detail, reviewing all prior test results and consultations. Geisler sits with Abid to fill out the 10-page “Multidisciplinary Diagnostic Approach for Patients Suspected of Lyme,” a standardized questionnaire. There’s a cognitive assessment as well. Geisler then does a thorough, 30-minute physical exam, an EKG, and reports her findings to Goehringer.

Almost all of Abid’s tests for Lyme and other diseases are negative, except one 100 euro test from Germany that often returns false positives. His western blots, which would confirm the presence of proteins related to the Lyme bacteria, are all negative.

Dr. David Scales, left, with Lyme disease clinic staff Dr. Francois Goehringer, center, and Dr. Marie Geisler. (Courtesy)
Dr. David Scales, left, with Lyme disease clinic staff Dr. Francois Goehringer, center, and Dr. Marie Geisler. (Courtesy)

“He has no objective evidence of Lyme,” Goehringer said after reviewing all the files. But Abid’s parathyroid hormone  which controls calcium and bone health  is elevated. It could be an explanation for some of Abid’s symptoms. Endocrinologists aren’t part of the Lyme clinic, but Geisler books him for a rapid follow-up appointment to check into it.

Like all patients who come to the clinic, Abid also sees Lorraine Callins, a psychologist who specializes in chronic illness and hypnotherapy. Many of her chronic autoimmune disease or hemophilia patients “feel abandoned by medicine, so they seek other roads,” she says.

If his symptoms warranted it, Abid would also have seen a rheumatologist or neurologist – common specialties for people with suspected Lyme symptoms.

Goehringer sees only four patients every Friday and has seen about 100 patients total since the one-stop-shop program began in January. He also aims to start a monthly meeting of various specialists to develop plans for some of the most challenging patients.

Some American clinics hope to organize similar one-stop shops. But since we have a fee-for-service system, expensive specialists are difficult to organize unless there is sufficient patient volume. It’s not impossible here, but it’s quite a financial challenge.

France faces its own challenges: The national Lyme plan aims to improve medical care, including with clinics like Goehringer’s, and sets ambitious targets to develop standardized treatment guidelines by the end of 2017. That appears unlikely, with doctors and Lyme advocacy groups still far apart on what the guidelines should be.

But while standardized guidelines are in the works, the Nancy clinic will at least offer a respite for patients who have spent months seeing myriad specialists in search of a diagnosis.

Will it improve outcomes? It’s too early to tell, but at least from the patient’s point of view it’s a step forward as it streamlines what is usually a months-long process into a single day.

Crossing Cultures

Maybe my starting point — What we can learn from the French? — wasn’t a fair one. We have deeply different health systems that reflect different cultures. France provides some of the best overall health care in the world and has a long tradition of viewing health care as a right, even enshrined in their constitutions.

It also has a national health system that pays for medical care. In this cultural context, spending on public health and prevention isn’t just seen as the right thing to do, but a way to reduce health costs later.

In contrast, in the U.S. we spend the most money on health care per person in the world, but don’t get more bang for our buck.

There are some hopeful signs of support for our fight against Lyme disease: The U.S. federal government has recently committed $40 million to create four regional centers of excellence for vector-borne diseases — which include Lyme — as part of its efforts to control the Zika virus.

But most of that money is expected to go toward fighting Zika, so it will likely do little to help fill the public health funding gaps that are leaving us far behind France in the fight against Lyme.

Reporting for this project was supported by the Pulitzer Center for Crisis Reporting. Dr. David Scales, MD, Ph.D. is an internal medicine physician at Cambridge Health Alliance and an instructor at Harvard Medical School. His doctorate in sociology included examining national flu pandemic preparedness plans while at the World Health Organization. He can be found on Twitter @davidascales.

This segment aired on August 16, 2017.


**Comment**

  • The 40 million going to regional centers for excellence in the U.S. needs to be watch-dogged as the author is correct in his statement that the preponderance of that money will be ear-marked for Zika, a disease that has caused 254 symptomatic cases of which 251 are from travelers returning from affected areas (outside the U.S.), 0 cases through presumed local mosquito-borne transmission, and 3 cases acquired through sexual transmission.  https://www.cdc.gov/zika/reporting/2017-case-counts.html The CDC currently is estimating over 300,000 new cases of Lyme Disease EACH YEAR and the true number to likely be much higher.  https://www.cdc.gov/lyme/stats/humancases.html

Anyone out there see the disparity yet?

More on Zika:  https://madisonarealymesupportgroup.com/2016/12/21/how-zika-got-the-blame/

https://madisonarealymesupportgroup.com/2016/04/08/zika-ebola-zombies-and-the-cdc/

https://madisonarealymesupportgroup.com/2016/07/17/zika-in-the-land-of-oz/

https://madisonarealymesupportgroup.com/2016/03/08/fixation-on-zikapolio/

https://madisonarealymesupportgroup.com/2016/10/26/zika-puzzling-scientists/

https://madisonarealymesupportgroup.com/2016/03/04/health-policy-recap/

Of Birds and Ticks

http://mainepublic.org/post/battle-against-ticks-and-lyme-disease-scientists-look-skies#stream/0

In the Battle Against Ticks and Lyme Disease, Scientists Look to the Skies

  JUL 3, 2017

As we head into the Maine outdoors this summer, the all-too-familiar warnings about how to avoid ticks reverberate in many of our heads.

Stay on the trail. Steer clear of wooded and brushy areas where ticks congregate.

But while most of us take pains to dodge the eight-legged pests, Chuck Lubelczyk heads straight for them.

As a field biologist at the Maine Medical Center Research Institute’s Lyme and Vector-Borne Disease Laboratory, he studies the spread of diseases carried by ticks, as well as by mosquitoes. That means venturing out into the fields, forests and coastlines of Maine to collect the bugs and evaluate where they pose the most risk to humans.

On a recent June day, Lubelczyk trudged into the greenery of the Wells Reserve, a 2,250-acre spread in York County headquartered at a restored saltwater farm. He partnered with researchers from the Biodiversity Research Institute in Portland to collect ticks from creatures less often associated with them: birds.

The team, assisted by several interns, set up wide nets to ensnare the birds as they flew through the area. They then delicately extricated them, tucked the birds into breathable collection bags, and toted them to a shady picnic table for easier handling. Using tweezers, the team plucked off each tick — typically feasting around the birds’ eyes, bills, and throats — and preserved the bugs for later testing at the lab.

Lubelczyk held up a vial containing at least 50 tiny nymphal deer ticks swirling in a preservative solution. They’d been tweezed off a single bird, a towhee, that morning.

Once free of ticks, the birds were then safely released to continue on their way.

https://bangordailynews.com/video/ticks-on-migratory-birds/ (Video here)

While mice, chipmunks and deer get most of the attention as hosts for ticks, “Not a lot of people talk about the bird issue,” he said. “They’re understudied in a big way, I think. They do have a real role to play.”

Ticks are an annoyance to birds, but they don’t transmit disease to them or slowly and lethally drain them of blood, as researchers have seen among moose calves in Maine. But birds facilitate the spread of ticks, picking them up in Maryland, Connecticut and other eastern states as they fly north in the spring, Lubelczyk explained.

“As they’re migrating, they’re either dropping the ticks off as they fly or when they land. They’re kind of seeding them along migration patterns.”

Emerging diseases

By tracking the birds and the ticks they carry, researchers hope to predict where Lyme and other tick-borne diseases are most likely to accelerate. Lyme is now present in every county in the state, after hitting a record of 1,488 cases in 2016, but ticks are just getting established in areas such as Aroostook and Washington counties, Lubelczyk said.

Along with Lyme, Lubelczyk tested the ticks for other two other emerging diseases, anaplasmosis and the rare but potentially devastating Powassan virus. Powassan, carried by both the deer tick and the groundhog or woodchuck tick, recently sickened two people in midcoast Maine, following the death in 2013 of a Rockland-area woman.

A recent survey Lubelczyk led found the virus in ticks crawling around southern Maine, Augusta and on Swan’s Island in Hancock County.

In the modest Scarborough lab, medical entomologist Rebecca Robich furthered the findings of that survey. Clad in a white coat and blue gloves, she cloned a tiny band of the Powassan virus’ inactivated RNA, using a sample derived from the ticks that tested positive in the survey. Robich began the work, designed to confirm the earlier test results, last winter.

She expects to know conclusively within the next month what percentage of the sampled ticks were infected with Powassan, she said.

“We’re this close to finishing,” Robich said.

Growing exposure

Ticks have become so prevalent in Maine that Lubelcyzk and his colleagues are increasingly called upon to educate the public about the health risks the arachnids pose. That includes speaking at community forums, town meetings, garden clubs and even to groups of employees.

“They’re widespread enough now that DOT, CMP, people like that are bumping into them on a regular basis,” he said. “Even people like law enforcement. The warden service, regular police with police dogs, they’re exposed.”

Their outreach also includes plenty of phone calls to the lab, fielded by its small staff of four, not counting summer interns.

“If somebody calls, we never really turn them down,” he said.

Many people don’t realize that the lab no longer identifies ticks for the public, Lubelczyk said. Now located in Scarborough along with MMC’s medical and psychiatric research centers, the lab formerly operated in South Portland, where it identified a tick’s species for anyone who walked in the door or mailed a sample. The University of Maine Cooperative Extension in Orono has since taken over that service (it does not test ticks for disease).

“It’s very hard to say no to someone when they’re really frantic because they found a tick on themselves, or their child, or even their pet,” he said. “And they’re sitting out in the parking lot.”

So far this season, the lab has fielded numerous calls from worried residents only to discover after viewing a photograph that the tick in question is a dog tick, not a deer tick. Maine is home to 15 species of ticks, and the dog tick is not among those that transmit disease to humans, at least in this region.

Through its outreach work, the lab has also found itself at the center of debates about how to manage ticks. Lubelczyk recalled a town forum on Long Island a couple of years ago that grew tense as residents discussed the use of pesticides.

“As soon as the topic of any kind of spray was brought up, not even by us, by somebody else, the fishing community was dead set against it,” he said. “Understandably, they’re worried about the stock. It really makes that difficult because you start to have divisions in how to control the ticks.”

The lab’s research on the role of birds in spreading tick-borne disease is similarly delicate, because many birds are under threat ecologically, Lubelczyk said.

“No one really cares if you try to target mice. Birds are federally protected in a lot of cases,” he said.

That other biting pest

Educating the public represents a large part of the lab’s mission but only a small part of its budget. Its outreach work is funded largely through small grants from foundations, Lubelczyk said.

Most of its research funding is targeted toward mosquitoes rather than ticks, boosted by the federal government’s initiative to combat the Zika virus, he said. While Zika hasn’t appeared in Maine, warming temperatures due to future climate change could make the state habitable for one of the mosquito species that carries it.

Lubelczyk explained this as he stood in the lab’s testing area, next to a large freezer storing petri dishes packed with frozen mosquitoes. A piece of yellow tape affixed to the door warned, “Not for food.”

While Lyme is far more prevalent, diseases carried by mosquitoes, such as West Nile virus and Eastern Equine Encephalitis, can lead to more acute illness. Both can cause inflammation of the brain and other serious complications.

Funding for tick research is generally less reliable, Lubelczyk said. The recent Powassan survey, for example, was funded by the Maine Outdoor Heritage Fund, which collects money through the sale of instant scratch lottery tickets.

A continuing threat

The lab’s role in helping to prevent tick-borne diseases has only grown as the tick population and the diseases they carry spread. The incidence of Lyme in Maine is among the highest rates in the country, averaging 82.5 cases per 100,000 people between 2013 and 2015.

Anaplasmosis and babesiosis are less common but becoming increasingly worrisome.

Lubelczyk understands the illnesses on both a professional and personal level. He contracted Lyme several years ago, after a deer tick latched onto him while he made a pitstop on the way home from work one steamy July day, he said. He had just changed into shorts and sandals and jumped out of his car for 30 seconds to hang a mosquito trap in Wells, he recalled.

A day and a half later, he spotted the tick bite. After a round of antibiotics, he recovered, Lubelczyk said.

His usual garb for field work includes long sleeves and pants treated with permethrin, along with gaiters over his boots.

“It’s embarrassing,” he said, wincing. “We always talk about wearing appropriate clothing.”

 

**Comment**

I’m thankful someone is dealing with the bird issue in relation to tick propagation as I believe it will be found to be much more of an issue than previously thought.  It would help explain why folks insist they’ve been infected while near trees as birds would drop them onto trees (as well as various rodents).  Like deer, birds serve primarily as transits that can spread ticks far and wide.

While Lubelczyk doesn’t feel dog ticks are important carriers (at least in his area) – he’s mistaken.  Every tick should be suspect until proven otherwise.  Think about it:  they all exchange bodily fluids with their hosts.  Dog ticks are known to carry Tularemia, https://www.cdc.gov/ticks/diseases/index.html Rocky Mountain Spotted Fever, Ehrlichia, Mediterranean Spotted Fever, Babesia in dogs (which should also make it suspect for humans), and potentially Bartonella.  http://labs.russell.wisc.edu/wisconsin-ticks/rhipicephalus-sangineus/  No, it would not be wise to think of the Dog Tick in friendly terms.  Remember that ticks are moving all over the place defying commonly held beliefs about geography.  And while folks fighting for research grants want to promote and blame the supposed “global warming” mentioned in this article, there are many who disagree for good reasons:  https://madisonarealymesupportgroup.com/2017/07/08/global-warming-numbers-fudged/

https://madisonarealymesupportgroup.com/2017/08/14/canadian-tick-expert-climate-change-is-not-behind-lyme-disease/  John explains, “The climate change range expansion model is what the authorities have been using to rationalize how they have done nothing for more than thirty years. It’s a huge cover-up scheme that goes back to the 1980’s. The grandiose scheme was a nefarious plot to let doctors off the hook from having to deal with this debilitating disease. I caught onto it very quickly. Most people have been victims of it ever since.”
“This climate change ‘theory’ is all part of a well-planned scheme. Even the ticks are smarter than the people who’ve concocted this thing,” he says.
“Climate change has nothing to do with tick movement. Blacklegged ticks are ecoadaptive, and tolerate wide temperature fluctuations. On hot summer days, these ticks descend into the cool, moist leaf litter and rehydrate. In winter, they descend into the leaf litter, and are comfortable under an insulating blanket of snow. Ticks have antifreeze-like compounds in their bodies, and can tolerate a wide range of temperatures. For instance, at Kenora, Ontario, the air temperature peaks at 36°C and dips to –44°C, and blacklegged ticks survive successfully.

Also, please note that although there has only been one Zika death in an elderly man with a preexisting health condition the continental U.S., all the funding is going to it and mosquito research.  This is causing untold harm here where Lyme is causing around 400,000 new cases per year.  There is no official tally on all the other coinfections they often come with Lyme as they aren’t even reportable in many states but are a crucial detail in understanding the complexity of Lyme/MSIDS.  People are often infected with numerous pathogens.  https://madisonarealymesupportgroup.com/2017/07/01/one-tick-bite-could-put-you-at-risk-for-at-least-6-different-diseases/

To treat this complex as a one organism/one disease would be folly.  

Also, he claims that West Nile virus and Eastern Equine Encephalitis, can lead to more acute illness, I would disagree again.  Lyme (borrelia), Babesia, Bartonella, Mycoplasma, and numerous other viruses, and funguses have killed people outright.  Heart block, encephalitis, meningitis, and other serious illnesses are caused by TBI’s. Powassan can be transmitted in under 15 minutes and can kill. Rocky Mountain Spotted Fever is another killer.  There is much to show that if the non-cell wall and biofilm formation of borrelia isn’t successfully dealt with, it could lead to dementia or Alzheimer’s in the future:  https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/https://madisonarealymesupportgroup.com/2016/06/09/alzheimers-byproduct-of-infection/https://madisonarealymesupportgroup.com/2017/01/18/a-bug-for-alzheimers/

And of course, while many cases of Lyme (borrelia) don’t kill immediately, it can make you want to die and disrupt life in such a way people commit suicide.  https://madisonarealymesupportgroup.com/2017/06/20/suicide-lyme-and-associated-diseases/https://madisonarealymesupportgroup.com/2017/07/26/can-lyme-steal-your-mind/

If that isn’t serious, I don’t know what is.

 

 

 

Wolbachia – The Next Frankenstein?

Transmission electron micrograph of Wolachia within an insect cell

Credit:  Public Library of Science/Scott O’Neill

The latest in the effort for world domination over bugs and the diseases they carry is Wolbachia, a Gram-negative bacterium of the family Rickettsiales first found in 1924 and in 60% of all the insects, including some mosquitoes, crustaceans, and nematodes (worms). For those that like numbers, that’s over 1 million species of insects and other invertebrates. It is one of the most infectious bacterial genera on earth and was largely unknown until the 90’s due to its evasion tactics. It’s favorite hosts are filarial nematodes and arthropods.

Wolachia obtains nutrients through symbiotic relationships with its host. In arthropods it affects reproductive abilities by male killing, parthenogenesis, cytoplasmic incompatibility and feminization. However, if Wolbachia is removed from nematodes, the worms become infertile or die. These abilities are what make it so appealing for insect controlcytoplasmic incompatibility, which essentially means it results in sperm and eggs being unable to form viable offering.

http://www.slideserve.com/babu/wolbachia  (Nifty slide show here)

It also makes it appealing for use in human diseases such as elephantiasis and River Blindness caused by filarial nematodes, which are treated with antibiotics (doxycycline) targeting Wolbachia which in turn negatively impacts the worms. Traditional treatment for lymphatic Filariasis is Ivermectin but they also use chemotherapy to disrupt the interactions between Wolbachia and nematodes. This anti-Wolbachia strategy is a game-changer for treating onchocerciasis and lymphatic filariasis.  https://www.sciencedaily.com/releases/2017/03/170316120451.htm

Lyme/MSIDS patients often have nematode involvement.

https://microbewiki.kenyon.edu/index.php/Wolbachiahttps://www.psychologytoday.com/blog/emerging-diseases/200902/tick-menagerie-lyme-isnt-the-only-disease-you-can-get-tick  Both Willy Burgdorfer, the discoverer of the Lyme bacterium, as well as Richard Ostfeld, an animal ecologist found nematode worms in ticks. Since then, some provocative research involving nematodes, Lyme/MSIDS, dementia, and Alzheimer’s has been done.

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/https://madisonarealymesupportgroup.com/2016/07/10/greg-lee-excellent-article-on-strategies-for-neurological-lyme/https://madisonarealymesupportgroup.com/2015/10/18/psychiatric-lymemsids/

https://www.scientificamerican.com/article/how-a-tiny-bacterium-called-wolbachia-could-defeat-dengue/  Yet, according to many, Wolbachia is the next eradicator of Dengue Fever and possibly Malaria, chikungunya, and yellow fever because it stops the virus from replicating inside mosquitoes that transmit the diseases. The approach is also believed to have potential for other vector-borne diseases like sleeping sickness transmitted by the tsetse fly.  Evidently, Wolbachia does not infect the Aedes aegypti mosquito naturally, so researchers have been infecting mosquitoes in the lab and releasing them into the wild since 2011. The article states it hopes that the method works and expects infection rates in people to drop and hopes that the mosquitoes will pass the bacterium to their offspring, despite it disappearing after a generation or two of breeding and needing to “condition” the microbes to get them used to living in mosquitoes before injecting them. They also state Wolbachia is “largely benign for mosquitoes and the environment,” and “To humans, Wolbachia poses no apparent threat.” Their work has shown that the bacterium resides only within the cells of insects and other arthropods. They also state that tests on spiders and geckos that have eaten Wolbachia mosquitoes are just fine and show no symptoms. An independent risk assessment by the Commonwealth Scientific and Industrial Research Organizatioin (CSIRO), Australia’s national science agency, concluded that, “Release of Wolbachia mosquitoes would have negligible risk to people and the environment.”

Interestingly, trials are underway in Vietnam, Indonesia, and now Brazil.

They state that scaling up operations to rear enough Wolbachia mosquitoes is too labor-intensive and in Cairns they are going to put Wolbachia mosquito eggs right into the environment. Evidently, other researchers are wanting to release genetically modified (GMO) mosquitoes that carry a lethal gene, and they’ve done it, and it’s causing an uproar:   http://america.aljazeera.com/articles/2013/11/9/genetically-modifiedmosquitoessetoffuproarinfloridakeys.html

http://www.naturalnews.com/2017-07-25-googles-sister-company-releasing-20-million-mosquitoes-infected-with-fertility-destroying-bacteria-depopulation-experiment.html  As of July 14, 2017, Google’s bio-lab, Verily Life Sciences,  started releasing Wolbachia laced mosquitoes in California as part of project, Debug Fresno to reduce the mosquito population.

http://www.greenmedinfo.com/blog/research-exposes-new-health-risks-genetically-modified-mosquitoes-and-salmon  Numerous studies show unexpected insertions and deletions which can translate into possible toxins, allergens, carcinogens, and other changes.  Science can not predict the real-life consequences on global pattens of gene function.

So, why question the use of Wolbachia as a bio-control?

For Lyme/MSIDS patients, 3 words: worms and inflammation.

Dogs treated for heart worm (D. immitis) have trouble due to the heart worm medication causing Wolbachia to be released into the blood and tissues causing severe Inflammation in pulmonary artery endothelium which may form thrombi and interstitial inflammation. Wolbachia also activates pro inflammatory cytokines. Pets treated with tetracycline a month prior to heart worm treatment will kill some D. immitis as well as suppress worm production. When given after heart worm medication, it may decrease the inflammation from Wolbachia kill off.
http://www.critterology.com/articles/wolbachia-and-their-role-heartworm-disease-and-treatment

The words worms and inflammation should cause every Lyme/MSIDS patient to pause. Many of us are put on expensive anthelmintics like albendazole, ivermectin, Pin X, and praziquantel to get rid of worms and are told to avoid anything causing inflammation due to the fact we have enough of it already. We go on special anti-inflammatory diets and take systemic enzymes and herbs to try and lower inflammation.   https://madisonarealymesupportgroup.com/2016/04/22/systemic-enzymes/

Seems to me, many MSIDS/LYME patients when treated with anthelmintics, will have Wolbachia released into their blood and tissues causing wide spread inflammation, similarly to dogs.

And that’s not all.

According to a study by Penn State, mosquitoes infected with Wolbachia are more likely to become infected with West Nile – which will then be transmitted to humans.“This is the first study to demonstrate that Wolbachia can enhance a human pathogen in a mosquito, one researcher said. “The results suggest that caution should be used when releasing Wolbachia-infected mosquitoes into nature to control vector-borne diseases of humans.” “Multiple studies suggest that Wolbachia may enhance some Plasmodium parasites in mosquitoes, thus increasing the frequency of malaria transmission to rodents and birds,” he said.  The study states that caution should be used when releasing Wolbachia-infected mosquitoes into nature. https://www.sciencedaily.com/releases/2014/07/140710141628.htm

So besides very probable wide spread inflammation, and that other diseases may become more prevalent due to Wolbachia laced mosquitoes, studies show Wolbachia enhances Malaria in mosquitos. Lyme/MSIDS patients are often co-infected with Babesia, a malarial-like parasite that requires similar treatment and has been found to make Lyme (borrelia) much worse. It is my contention that the reason many are not getting well is they are not being treated for the numerous co-infections.  Some Lyme/MSIDS patients have Malaria and Lyme.

Regardless of what the CDC states, all the doxycycline in the world is not going to cure this complicated and complex illness.

Lastly, with Brazil’s recent explosion of microcephaly, the introduction of yet another man-made intervention (Wolbachia laced mosquitos) should be considered in evaluating potential causes and cofactors. And while the CDC is bound and determined to blame the benign virus, Zika, there are numerous other factors that few are considering – as well as the synergistic effect of all the variables combined. Microcephaly could very well be a perfect storm of events.
https://madisonarealymesupportgroup.com/2016/12/21/how-zika-got-the-blame/https://madisonarealymesupportgroup.com/2016/03/04/health-policy-recap/https://madisonarealymesupportgroup.com/2016/03/08/fixation-on-zikapolio/

I hate bugs as much as the next person, but careful long-term studies of Wolbachia are required here.

https://www.ncbi.nlm.nih.gov/pubmed/20394659  “Despite the intimate association of B. burgdorferi and I. scapularis, the population structure, evolutionary history, and historical biogeography of the pathogen are all contrary to its arthropod vector.

In short, borrelia (as well as numerous pathogens associated with Lyme/MSIDS), is a smart survivor.

While borrelia have been around forever with 300 strains and counting worldwide, epidemics, such as what happened with Lyme Disease in Connecticut are not caused by genetics but by environmental toxins – in this case, bacteria, viruses, funguses, and stuff not even named yet.

Circling back to Wolbachia.

Hopefully it is evident that many man-made interventions have been introduced into the environment causing important health ramifications: Wolbachia laced mosquitoes and eggs, GMO mosquitoes including CRISPR, and in the case of Zika in Brazil, whole-cell pertussis vaccinations (DTap) for pregnant women up to 20 days prior to expected date of birth, a pyriproxyfen based pesticide applied by the State in Brazil on drinking water, as well as aerial sprays of the insect growth regulators Altosid and VectoBac (Aquabac, Teknar, and LarvX, along with 25 other Bti products registered for use in the U.S.) in New York (Brooklyn, Queens, Staten Island, and The Bronx) to combat Zika. “We feel it’s critical that the scientific community consider the potential hazards of all off-target mutations caused by CRISPR, including single nucleotide mutations and mutations in non-coding regions of the genome … Researchers who aren’t using whole genome sequencing to find off-target effects may be missing potentially important mutations. Even a single nucleotide change can have a huge impact.”  http://articles.mercola.com/sites/articles/archive/2017/06/13/crispr-gene-editing-dangers.aspx?utm_source=dnl&utm_medium=email&utm_content=art3&utm_campaign=20170613Z1_UCM&et_cid=DM147520&et_rid=2042753642

All of this is big, BIG business.

Is the introduction of Wolbachia another puzzle piece in the perfect storm of events causing or exacerbating human health issues?

The jury’s still out, but it’s not looking good – particularly for the chronically ill.

Michigan Study Finds Anti-Zika Chemicals Impact Infant Motor Skills

http://www.ns.umich.edu/new/releases/24890-chemicals-used-to-combat-zika-agricultural-pests-impact-motor-skills-in-infants

June 8, 2017  Laurel Thomas Gnagey:  Michigan News

Researchers at the U-M School of Public Health and U-M Center for Human Growth and Development tested children in China and found exposure to the chemical naled via their mothers during pregnancy was associated with 3-4 percent lower fine motor skills scores at age 9 months for those in the top 25 percent of naled exposure, compared to those in the lowest 25 percent of exposure. Infants exposed to chlorpyrifos scored 2-7 percent lower on a range of key gross and fine motor skills.

Girls appeared to be more sensitive to the negative effects of the chemicals than boys.

Naled is one of the chemicals being used in several U.S. states to combat the mosquito that transmits Zika. Chlorpyrifos, around since the 1960s, is used on vegetables, fruit and other crops to control pests.

Both are insecticides called organophosphates, a class of chemicals that includes nerve agents like sarin gas. They inhibit an enzyme involved in the nerve signaling process, paralyzing insects and triggering respiratory failure. However, they may adversely impact health through other mechanisms at lower exposure levels that are commonly encountered in the environment.

“Motor delays in infancy may be predictive of developmental problems later in childhood,” said first author Monica Silver, graduate student research assistant and research fellow in the School of Public Health Department of Environmental Health Sciences. “The findings may help inform policy as the debate over use of these chemicals continues.”

The only studies to date on naled health impacts have taken place in occupational settings, not with exposure in the general population, Silver says. Previous chlorpyrifos research has found ties to delayed motor development in children and a host of health issues for those who handle the chemical, including nausea, dizziness and convulsions.

**Comment**

This is another great example of a myopic view on a problem to the detriment of public health.  Much like the Lyme vaccine which uses OspA and causes chronic Lyme symptoms in many people, many pesticides are wrecking havoc on public health as noted by the University of Michigan. and many, many other sources.

Why?

http://www.naturalnews.com/055293_Zika_virus_birth_defects_profits.html  Scott Adams, author of Natural News, has come up with five industries with agendas that stand to gain from a Zika scare including: chemical companies, vaccine makers, biotech industry (GMO mosquitoes), and Planned Parenthood and the condom industry since the disease is believed to be spread sexually.

Let us not forget governmental agencies and researchers as they typically obtain grant money for their research that is highly dependent upon what I call “curb appeal.”  In other words, the best way to get money in the 21st century is to whoop something up using the media to obtain funding as well as career advancement, prestige, and essentially power.  http://www.pewinternet.org/2015/02/15/how-scientists-engage-public/  Even though nearly 80% of scientists acknowledge that science news coverage doesn’t distinguish between well-founded and not well-founded findings.

For a refresher of how it all went down with Zika:  https://madisonarealymesupportgroup.com/2016/12/21/how-zika-got-the-blame/ Despite the CDC initially denying a causal link between Zika and microcephally, CDC authors then plopped one paper into a formula of which the paper only met 3 of 7 criteria and they did an about face.  

For more on Zika: https://madisonarealymesupportgroup.com/2016/03/08/fixation-on-zikapolio/
https://madisonarealymesupportgroup.com/2016/07/17/zika-in-the-land-of-oz/
https://madisonarealymesupportgroup.com/2016/10/26/zika-puzzling-scientists/
https://madisonarealymesupportgroup.com/2016/03/04/health-policy-recap/
https://madisonarealymesupportgroup.com/2016/04/08/zika-ebola-zombies-and-the-cdc/

What can really cause microcephally, not to mention cancer?

https://madisonarealymesupportgroup.com/2016/11/14/naled-causes-microcephaly/  

Naled’s breakdown product DICHLORVOS (another organophosphate insecticide) interferes with prenatal brain development. In laboratory animals, exposure for just 3 days during pregnancy when the brain is growing quickly reduced brain size 15 percent. https://www.ncbi.nlm.nih.gov/pubmed/8065512

DICHLORVOS also causes cancer, according to the International Agency for Research on Carcinogens. In laboratory tests, it caused leukemia and pancreatic cancer. Two independent studies have shown that children exposed to household “no-pest” strips containing dichlorvos have a higher incidence of brain cancer than unexposed children.

Aerial applications of naled can drift up to one-half mile. According to the U.S. Environmental Protection Agency, naled is moderately to highly toxic to birds and fish. It also reduced egg production and hatching success in tests with birds and reduced growth in tests with juvenile fish. convulsions, paralysis, and death.”

UWM – Center of Excellence Vector Borne Diseases

http://news.wisc.edu/cdc-awards-10-million-for-insect-borne-disease-center/

University of Madison-Wisconsin News

MADISON – The Centers for Disease Control and Prevention (CDC) has awarded $10 million to a consortium of Midwestern universities to establish a new research and training program to stem the spread of disease carried by vectors like ticks and mosquitoes.

The Upper Midwestern Center of Excellence in Vector Borne Diseaseshttp://grantome.com/grant/NIH/U01-CK000505-01 which will be led by University of Wisconsin–Madison medical entomologists Lyric Bartholomay and Susan Paskewitz, is aimed at elevating the understanding of vector borne diseases and improving public health response to diseases like Zika, West Nile and Lyme disease.

Part of a larger push by CDC to buttress the nation’s public health infrastructure to thwart vector borne diseases, including emerging diseases like Zika and West Nile, the new center will involve scientists – public health entomologists, epidemiologists, virologists and vector control experts – from UW–Madison, the University of Illinois, the University of Iowa, the University of Michigan and the Minnesota Department of Health.

A key objective of the new center, says Bartholomay, a professor of pathobiological sciences in the UW–Madison School of Veterinary Medicine, is to foster collaboration not only between university experts, but also with public health organizations at the local, state and federal levels. The goal, she explains, is to boost surveillance, prevention and response against the backdrop of a trend toward the emergence of new diseases and old diseases – like Zika and West Nile – in regions far from their places of origin.

The Midwest, according to Paskewitz and Bartholomay, is a “national hotspot for disease emergence and endemic transmission of vector borne disease.”

“There is a trend toward new emerging disease,” says Paskewitz, who chairs UW–Madison’s entomology department. “We’re seeing invasions of new species and pathogens. It is these new things moving around.”

The deer tick is one of the most important disease vectors in Wisconsin and will be under the microscope as a new center for vector borne disease takes shape at UW–Madison.

For example, not only are new tick species such as the lone star tick showing up in places like Wisconsin, places where they didn’t live before, but they are carrying a wider variety of disease. When Paskewitz joined the UW–Madison faculty in 1991, Lyme disease was the only known tick-borne disease endemic to Wisconsin. Today, she says there are at least half a dozen diseases that can be transmitted by the blood-sucking arachnids found in the Badger State.

There are likely a number of reasons why new vector borne diseases are on the rise in the Midwest. Changes to the landscape such as deforestation and urbanization, shifts in animal populations such as white-tailed deer, and changes in climate all are likely contributors, according to the Wisconsin scientists. Another possibility, says Paskewitz, is that scientists are simply getting better at finding new invasive species of mosquitoes and ticks and their bacterial and viral pathogens.

The new CDC-supported center will have three primary objectives:

*Grow the cadre of public health entomologists. Increased opportunities for graduate training in the field, and a new certificate program that will equip students to better identify vectors, conduct disease surveillance and use the appropriate tools to reduce insect populations.
*Create a network of scientists, mosquito control, and public health experts and officials at the local and state levels to better coordinate and facilitate surveillance and response to outbreaks of disease.
*Conduct research to improve and devise new methods to predict disease emergence and outbreaks as well as to optimize surveillance networks and pathogen detection. Research will also focus on evaluating and improving methods for controlling disease vectors like mosquitoes and ticks, with the ultimate goal of reducing human risk and exposure.
“Our vision is to provide training at all levels, including the undergraduate, graduate and professional levels,” says Bartholomay. “We hope we can provide a conduit of really well trained people who will be positioned to respond to outbreaks.”

The certificate program and training opportunities will be available at all of the partner institutions.

Research, say Paskewitz and Bartholomay, will be essential, as changing environmental conditions allow vectors and the diseases they carry to exploit new geographic regions and susceptible human and animal populations. “We don’t want to look for only what we expect,” explains Bartholomay. “We want to look for new diseases and understand the threats they pose.”

UW-Madison, she adds, is well positioned to do this through existing faculty, staff and technical resources, such as next-generation gene sequencing technologies that can be used to identify viral and bacterial pathogens associated with ticks and mosquitoes.

The new center will also have an outreach component. The idea, say Bartholomay and Paskewitz, will be to give the public access to region-specific information about tick and mosquito activity, ways to accurately identify vectors, and information about the pathogens transmitted by ticks and mosquitoes.

***If you are from Wisconsin, Illinois, Iowa, Michigan, or Minnesota, please call and make sure that a preponderance of this money is going into tick research.  When I spoke at the Wisconsin capital a year ago at the Evidence Based Health Policy Project:  https://madisonarealymesupportgroup.com/2016/03/04/health-policy-recap/ (please read), I spent considerable time discussing the plight of Lyme patients. That we are co-infected with numerous pathogens which make our cases far more complex than most realize. I spoke of borrelia, alone, and that it is pleomorphic with three shapes it can change into at will and that proper treatment needs to address this complexity and that 21 days of doxycycline, the current CDC standard of care is like throwing sand into the ocean. I spoke of 3 generations of Wisconsinites living under the same roof – all infected with MSIDS (multi systemic infectious disease syndrome). I explained that the myth that Lyme (borrelia) only causes a little joint pain and fatigue needs to be dispelled and that there is significant cognitive and psychological impairment with some suffering with severe anxiety, rage, confusion, depression, and memory loss.

I made it clear that Wisconsin should be focusing on ticks and the diseases they carry – NOT ZIKA, which according to Susan Paskewitz, Professor and Researcher, Medical Entomology Laboratory, UW Madison, Northern mosquitos can not even carry Zika. They have found some West Nile in mosquitos here.

 

 

 

A Bug for Alzheimer’s?

https://aeon.co/essays/how-microbial-infections-might-cause-alzheimers-disease

Please read the article above, written by Melinda Wenner Moyer, edited by Pam Weintraub.

A brief summary:

Robert Moir, a neurologist at Massachusetts General Hospital in Boston, believes that beta-amyloid, a key player in Alzheimer’s, might be a good guy who is actually protecting the brain from pathogens.

This idea is coming from numerous corners of the world and has been labeled ‘pathogen hypothesis.’ Others pointing this out are pathologist Alan MacDonald, neuropathologist Judith Miklossy, and microbiologist Tom Grier.

Moir has published mouse studies showing that their brains create amyloid plaques within hours of contracting infections and they actually kill pathogens.

This observation flies in the face of accepted dogma about beta-amyloid and it is rarely discussed in AD groups.

A meta-analysis of 25 published studies has shown that infected folks are 10 times more likely to develop AD, leading international researchers to co-sign an editorial begging others to consider pathogens in relation to AD.

But, the cabal isn’t having it. Moir’s 2016 paper was rejected six times without even a review before finally getting the nod.  https://madisonarealymesupportgroup.com/2017/01/13/lyme-science-owned-by-good-ol-boys/

The author reminds the reader that infections in the brain are nothing new and a short list of them includes: Syphillis, Herpes simplex encephalitis, tick borne disease, HIV, Toxoplasma gondii, Chlamydia pneumoniae, HSV-1, and Zika.

https://madisonarealymesupportgroup.com/2016/04/10/bugs-causing-alzheimers/

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/

https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/

http://www.huffingtonpost.com/david-michael-conner/man-diagnosed-with-als-di_b_8891262.html

The journalist also points out that pathogen causation is not proven and that Alzheimer’s patients might be prone to infection but that some studies suggest the infections came first. She also says that the majority of folks suggesting the ‘pathogen hypothesis’ do not feel the infections work alone but rather can cause a domino effect that over time can accumulate causing AD.

And lastly, if beta-amyloid causes AD then removing these plaques should get rid of symptoms, but when 145 beta-amyloid-reducing drugs were tested, not one slowed progression of the disease.

Once again, proving a science cabal exists, Moir recounts how at a Korean conference, attendees were asked to raised hands if they thought infections played a part in AD and a majority of hands went up.

“Ten years ago, it would have been four guys in a corner, all huddled together, not talking to anyone else, Moir says.

https://madisonarealymesupportgroup.com/2017/01/02/fake-science/

Isn’t that sad?

2016 Vaccine News

MSIDS patients are hit with an onslaught of vaccine messages, often from the very pharmacies they must call to order life-saving drugs for tick borne infections.  These messages are always one-sided, telling patients to get their vaccine(s) now.

MSIDS patients often feel so incredibly lousy that they literally have a challenge putting one foot in front of the other.  The very thought of needing to research vaccine information sends the very stoutest to bed for a nap, and even if they manage to do a little sleuthing, they can’t remember what they have read just 10 minutes later.

It is especially for you that this post is written.

Published on Dec 10, 2013
Doctors say the human papillomavirus vaccine, Gardasil, may prevent cervical cancer, but two sisters say they believe the drug made them infertile.  They are now suing the manufacturer.

For more on Gardisil:

https://madisonarealymesupportgroup.com/2016/07/19/motor-and-sensory-findings-in-girls-who-received-gardasil/

https://madisonarealymesupportgroup.com/2016/04/24/gardasil-and-bartonella/

Deaths from live Polio Vaccine:

http://www.thevaccinereaction.org/2016/12/two-children-die-after-polio-vaccination-four-in-critical-condition-in-pakistan/

“Two children in the Tehsil Bara area of the Khyber Agency tribal region in Pakistan reportedly died last week ‘moments’ after receiving the live oral poliovirus vaccine. Another 11 children, who had been administered the vaccine in Tehsil Bara, fell unconscious and were taken to Hayatabad hospital in the city of Peshawar. Four of the 11 children remain in critical condition.  

OPV has long been known to actually cause vaccine strain polio paralysis in some individuals who get the vaccine, as well as cause paralysis in some who come in close contact with recently vaccinated persons shedding vaccine strain polio virus in saliva, urine and other body secretions. According to the U.S. Centers for Disease Control and Prevention (CDC), “Cases of vaccine-associated paralytic poliomyelitis cases do occur in countries using oral poliovirus vaccine.”

While the US does not use the live polio vaccine any more, there has been an alarming increase in Acute Flaccid Paralysis (AFM), a neurological disease that closely resembles the poliovirus in the U.S.  http://www.thevaccinereaction.org/2016/11/mysterious-polio-like-illness-plaguing-children-stumps-cdc/.  Eighty-nine people across 33 states have confirmed AFM.

“AFM affects a person’s nervous system, particularly the spinal cord. Patients present with a fever or respiratory illness, then develop temporary paralysis. Among the 121 cases reported in 2014, only three children recovered fully, although 85 percent recovered partially.”

The question begging to be asked is does the shedding of the live polio vaccine actually cause the AFM we are seeing in the U.S.?

http://www.thevaccinereaction.org/2016/12/mercks-ebola-vaccine-a-christmas-gift-for-the-world-really/

Media claims “New Ebola Vaccine Gives 100 Percent Protection.”

What really happened:

**5,643 adults and 194 children in the West African country of Guinea were in contact with people with Ebola.

**65% were given a single dose of the rVSV-ZEBOV vaccine.  They reported no cases of Ebola after a designated window of 9 days.  Some did actually come down with Ebola but they weren’t counted because they assumed they were infected before vaccination.  (Remember the axiom, “Assuming makes an Ass out of u and me.”)

**35% were given the vaccine 21 days later.  These folks along with those who never received the vaccine had 23 cases of Ebola.

**The incubation period for Ebola is 2-21 days with an average of 8-10 days. http://www.who.int/mediacentre/factsheets/fs103/en/.  Is it good science to stop observation after 9 days on a disease that has a 25%-95% fatality rate?

**Two different sized groups are being compared. The group with no Ebola contains 16% less people than the group with 23 cases and may actually be greater than that, given that an unknown portion actually came down with Ebola but were not counted.

This is reminiscent of how the CDC suddenly decided that two fetal samples proves that Zika causes microcephaly:https://madisonarealymesupportgroup.com/2016/12/21/how-zika-got-the-blame/

http://www.forbes.com/forbes/welcome/?toURL=http://www.forbes.com/sites/stevensalzberg/2016/12/20/anti-vax-movement-to-blame-for-quadrupling-of-mumps-cases-this-year/&refURL=  A recent article in Forbes blames those choosing to forego the Mumps vaccine with causing mumps outbreaks even though most that contracted it had been fully vaccinated!

http://www.thevaccinereaction.org/2016/12/scapegoating-anti-vaxxers-for-the-mumps-outbreaks-how-predictable/  Here’s a great article showing the Forbes author doesn’t present any facts to bolster his claim but in typical form belittles anyone who choses informed consent in regards to vaccinations.

The take home:  Do your reading.  You are chronically ill with pathogen(s) that are already giving your immune system a run for its money.  Consider carefully what you allow into or onto your body.  As Dr. Burrascano has stated, “Now is the time for the very best of health habits.”  http://www2.lymenet.org/domino/file.nsf/UID/guidelines

It’s your body.  You decide.